ergotamine and Diseases, Peripheral Vascular

ergotamine has been researched along with Diseases, Peripheral Vascular in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lavonas, EJ; Srisuma, S; Wananukul, W1
Araki, H; Hayashi, M; Katsuura, Y; Kiyoki, M; Murakami, T; Sawada, K; Tanabe, H; Taneda, K1
Bock, K; Grassman, E; Johnson, SA; Lewis, B; Leya, F; McKiernan, TL; Scanlon, PJ1
Chee, YC; Tay, JC1
Borge, MA; D'Amore, MJ; Messersmith, RN1

Reviews

1 review(s) available for ergotamine and Diseases, Peripheral Vascular

ArticleYear
Ergotism and vascular insufficiency: a case report and review of literature.
    Annals of the Academy of Medicine, Singapore, 1998, Volume: 27, Issue:2

    Topics: Adult; Angiography; Caffeine; Central Nervous System Stimulants; Diagnosis, Differential; Drug Combinations; Ergotamine; Ergotism; Female; Humans; Leg; Peripheral Vascular Diseases; Vasoconstrictor Agents; Venous Insufficiency

1998

Other Studies

4 other study(ies) available for ergotamine and Diseases, Peripheral Vascular

ArticleYear
Ergotism and factitious hypotension associated with interaction of ergotamine with CYP3A4 inhibitors.
    Clinical toxicology (Philadelphia, Pa.), 2014, Volume: 52, Issue:7

    Topics: Adult; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Ergotamine; Ergotism; Fatal Outcome; Female; Humans; Hypotension; Infant; Male; Middle Aged; Peripheral Vascular Diseases; Poison Control Centers; Thailand; Treatment Outcome; Vasoconstrictor Agents

2014
Effect of isocarbacyclin methyl ester incorporated in lipid microspheres on experimental models of peripheral obstructive disease.
    Arzneimittel-Forschung, 1995, Volume: 45, Issue:9

    Topics: Alprostadil; Animals; Drug Carriers; Epinephrine; Epoprostenol; Ergotamine; Gangrene; Lauric Acids; Liposomes; Male; Peripheral Vascular Diseases; Rats; Rats, Wistar; Tail; Vasodilator Agents

1995
Ergot induced peripheral vascular insufficiency, non-interventional treatment.
    Catheterization and cardiovascular diagnosis, 1994, Volume: 31, Issue:3

    Topics: Adult; Analgesics, Opioid; Anticoagulants; Arteries; Ergotamine; Female; Humans; Leg; Migraine Disorders; Peripheral Vascular Diseases; Radiography; Renal Artery

1994
Limb-threatening lower extremity ischemia successfully treated with intra-arterial infusion--case reports.
    Angiology, 1999, Volume: 50, Issue:3

    Topics: Adult; Caffeine; Central Nervous System Stimulants; Drug Combinations; Ergotamine; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Ischemia; Leg; Middle Aged; Migraine Disorders; Papaverine; Peripheral Vascular Diseases; Plasminogen Activators; Raynaud Disease; Thrombosis; Tolazoline; Urokinase-Type Plasminogen Activator; Vasoconstrictor Agents; Vasodilator Agents

1999